Clinical Trial Update: Corneal Collagen Cross-Linking for the Treatment of Progressive Keratoconus and Corneal Ectasia [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update on corneal collagen cross-linking for progressive keratoconus and corneal ectasia. Phase 2/3 trials completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Corneal Ectasia
• Progressive Keratoconus

Drugs mentioned

• Corneal Collagen Cross-Linking (riboflavin-mediated corneal collagen cross-linking)

Snippet

Sponsor: Emory University | Conditions: Progressive Keratoconus, Corneal Ectasia | Phase 2, Phase 3 | Status: COMPLETED